Benzinga | Nov 1, 2021 06:19AM EDT

Capstar Special Purpose Acquisition Merging Partner Gelesis Announces Nature's Scientific Reports Features Gelesis' Novel and Foundational Biomimetic Platform for Treating Obesity and Conditions Related to Diet-Induced Gut Damage

New paper describes the first superabsorbent hydrogel technology made from naturally derived building blocks designed to address obesity and gut related conditions by emulating compositional and mechanical properties of raw vegetables

The newly published data showed that specific mechanical properties (elastic component/firmness) of Gelesis hydrogels were beneficial in protecting gut tissue from toxin damage in an ex-vivo model

First product based on this platform, Plenity(r), is now FDA cleared and available by prescription to aid in weight management

Gelesis' pipeline includes several other therapeutic product candidates in advanced clinical development to potentially treat a range of indications including diet-induced gut damage